Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion
2024

Sentinel Lymph Node Biopsy in Male Breast Cancer

Sample size: 153 Commentary Evidence: moderate

Author Information

Author(s): Cipolla Calogero, Gebbia Vittorio, D’Agati Eleonora, Greco Martina, Mesi Chiara, Scandurra Giuseppa, Sambataro Daniela, Valerio Maria Rosaria

Primary Institution: University of Palermo

Hypothesis

The application of sentinel lymph node biopsy (SLNB) in male breast cancer (MBC) remains underexplored, with limited male-specific data and treatment protocols often extrapolated from female breast cancer studies.

Conclusion

Sentinel lymph node biopsy shows high diagnostic accuracy in male breast cancer, but its long-term impact on clinical outcomes needs further research.

Supporting Evidence

  • Sentinel lymph node biopsy (SLNB) has emerged as a less invasive alternative to axillary lymph node dissection (ALND) for axillary staging in breast cancer.
  • Available evidence suggests that SLNB in men demonstrates high diagnostic accuracy, with low false-negative rates.
  • Despite its effectiveness, there is ongoing debate about the long-term impact of SLNB on clinical outcomes in male breast cancer.

Takeaway

This study looks at how a special test called sentinel lymph node biopsy can help find cancer in men with breast cancer, which is very rare. It shows that this test works well, but we need to learn more about how it helps men over time.

Methodology

The review synthesizes data from 12 retrospective studies evaluating SLNB identification rates and false-negative rates in male breast cancer.

Potential Biases

The reliance on data extrapolated from female breast cancer studies may introduce bias in treatment protocols for male patients.

Limitations

The studies included were retrospective and had small sample sizes, indicating a need for larger prospective trials.

Participant Demographics

The studies primarily involved men with early-stage breast cancer, with a focus on those with clinically negative axillary nodes.

Statistical Information

P-Value

p<0.01

Confidence Interval

97.1–101%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/curroncol31120557

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication